SCHEMBL30893164

SCHEMBL30893164

Cc1cc([C@H](C)OS(C)(=O)=O)c2oc(-c3ccccc3)c(C)c(=O)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 2/20 0.42
▸ CSNK2B P67870 2/20 0.42
▸ CSNK2A1 P68400 2/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PIK3CB P42338 3/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ LMNA P02545 4/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30893163 1.00 CSNK2A2 (0.42) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL24912996 0.82 ALDH1A1 (0.47) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL26662629 0.82 ALDH1A1 (0.47) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL31316385 0.82 ALDH1A1 (0.47) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL31035111 0.81 ALDH1A1 (0.46) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL24913011 0.81 ALDH1A1 (0.46) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL24912998 0.81 ALDH1A1 (0.49) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL30893165 0.81 ALDH1A1 (0.49) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL31035409 0.81 ALDH1A1 (0.49) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4
SCHEMBL26662473 0.81 ALDH1A1 (0.46) CSNK2A2CSNK2BCSNK2A1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612136-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE Petra Pharma Corporation (US) 2025-09-10 — — EP disclosed
WO-2024097205-A1 ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE PETRA PHARMA CORPORATION (US) 2024-05-10 — — WO disclosed
Send feedback